About
Endovascular Devices
Areas of Focus
Categories
Medical ImplantSurgical DeviceNorth & South Carolina
Clinical Trials (7)
View allTotal Trials
7
As Lead Sponsor
6
As Collaborator
1
Total Enrollment
3,442
By Phase
NA: 5PHASE1: 1
By Status
COMPLETED: 4ACTIVE_NOT_RECRUITING: 2RECRUITING: 1
Clinical Trials Pipeline7 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
2031
Today
Hover over trial bars to see details
Recent Trials
NCT06825715Collaborator
Multilevel Intervention for Precision Oncology
NARecruiting
2,653 participants
Started: Jul 2, 2025 · Completed: Feb 28, 2030
NCT05845710Lead Sponsor
Direct Access Carotid Artery Stenting Using the Neuroguard IEP System (PERFORMANCE III)
NAActive, not recruiting
178 participants
Started: Oct 5, 2023 · Completed: Dec 15, 2025
NCT04201132Lead Sponsor
Protection Against Emboli During Carotid Artery Stenting Using the Neuroguard IEP System
NAActive, not recruiting
305 participants
Started: Jun 12, 2020 · Completed: Dec 31, 2025
NCT04142541Lead Sponsor
Evaluation of the 3-in-1 Neuroguard IEP System for Carotid Artery Stenosis
NACompleted
67 participants
Started: Feb 28, 2018 · Completed: Feb 17, 2020
NCT03271710Lead Sponsor
Study to Evaluate the Lower Extremity Intervention With Integrated Embolic Protection Using the Vanguard IEP System
NACompleted
113 participants
Started: Sep 1, 2017 · Completed: Dec 30, 2018
Locations (1)
Headquarters
Raleigh, NC, United States
Map
Loading map...